TJUH Hematology and Medical Oncology

Topics

• Acute Myeloid Leukemia Research 788
• Hemoglobinopathies and Related Disorders 190
• Chronic Myeloid Leukemia Treatments 140
• Hematopoietic Stem Cell Transplantation 128
• Prostate Cancer Treatment and Research 105
• Cutaneous lymphoproliferative disorders research 95
• Lymphoma Diagnosis and Treatment 93
• Ocular Oncology and Treatments 92
• CAR-T cell therapy research 71
• Acute Lymphoblastic Leukemia research 67
• Multiple Myeloma Research and Treatments 65
• Chronic Lymphocytic Leukemia Research 61

Most cited

1. Non-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology

   Journal of the National Comprehensive Cancer Network : JNCCN · 2024 · 922 citations · Debora Bruno

2. Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2022 · 1,255 citations · Debora Bruno

3. Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis.

   The New England journal of medicine · 2023 · 550 citations · Mahasweta Gooptu

4. NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2021 · 813 citations · Debora Bruno

5. NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 2.2023.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 469 citations · Debora Bruno

6. Futibatinib for FGFR2-Rearranged Intrahepatic Cholangiocarcinoma.

   The New England journal of medicine · 2023 · 502 citations · Amit Mahipal